Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors of mortality among hospitalized COVID-19 patients and risk score formulation for prioritizing tertiary care-An experience from South India.
Gopalan N, Senthil S, Prabakar NL, Senguttuvan T, Bhaskar A, Jagannathan M, Sivaraman R, Ramasamy J, Chinnaiyan P, Arumugam V, Getrude B, Sakthivel G, Srinivasalu VA, Rajendran D, Nadukkandiyil A, Ravi V, Hifzour Rahamane SN, Athur Paramasivam N, Manoharan T, Theyagarajan M, Chadha VK, Natrajan M, Dhanaraj B, Murhekar MV, Ramalingam SM, Chandrasekaran P. Gopalan N, et al. PLoS One. 2022 Feb 3;17(2):e0263471. doi: 10.1371/journal.pone.0263471. eCollection 2022. PLoS One. 2022. PMID: 35113971 Free PMC article.
Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial.
Swaminathan S, Menon PA, Gopalan N, Perumal V, Santhanakrishnan RK, Ramachandran R, Chinnaiyan P, Iliayas S, Chandrasekaran P, Navaneethapandian PD, Elangovan T, Pho MT, Wares F, Paranji Ramaiyengar N. Swaminathan S, et al. Among authors: gopalan n. PLoS One. 2012;7(12):e47400. doi: 10.1371/journal.pone.0047400. Epub 2012 Dec 14. PLoS One. 2012. PMID: 23251327 Free PMC article. Clinical Trial.
Predictors of unfavorable responses to therapy in rifampicin-sensitive pulmonary tuberculosis using an integrated approach of radiological presentation and sputum mycobacterial burden.
Gopalan N, Srinivasalu VA, Chinnayan P, Velayutham B, Bhaskar A, Santhanakrishnan R, Senguttuvan T, Rathinam S, Ayyamperumal M, Satagopan K, Rajendran D, Manoharan T, Lakshmanan S, Paramasivam P, Angamuthu D, Ganesan M, Easudoss Arockia JW, Venkatesan RB, Lakshmipathy V, Shanmugham S, Subramanyam B, Shankar S, Mohideen Shaheed J, Dhanaraj B, Paranji Ramiyengar N, Swaminathan S, Chandrasekaran P. Gopalan N, et al. PLoS One. 2021 Sep 20;16(9):e0257647. doi: 10.1371/journal.pone.0257647. eCollection 2021. PLoS One. 2021. PMID: 34543329 Free PMC article.
Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial.
Gopalan N, Santhanakrishnan RK, Palaniappan AN, Menon PA, Lakshman S, Chandrasekaran P, Sivaramakrishnan GN, Reddy D, Kannabiran BP, Agiboth HKK, Krishnamoorthy V, Rathinam S, Chockalingam C, Manoharan T, Ayyamperumal M, Jayanthi N, Satagopan K, Narayanan R, Krishnaraja R, Sathiyavelu S, Kesavamurthy B, Suresh C, Selvachitiram M, Arasan G, Susaimuthu S, Rathinam P, Angamuthu P, Jayabal L, Murali L, Ramachandran R, Tripathy SP, Swaminathan S. Gopalan N, et al. JAMA Intern Med. 2018 Apr 1;178(4):485-493. doi: 10.1001/jamainternmed.2018.0141. JAMA Intern Med. 2018. PMID: 29507938 Free PMC article. Clinical Trial.
Pulmonary Mycobacterium kyorinense disease: A case report and review of literature.
Saranathan R, Padmapriyadarsini C, Sivaramakrishnan GN, Perumal BK, Kannayan S, Joseph B, Gopalan N, Hanna LE. Saranathan R, et al. Among authors: gopalan n. Indian J Med Microbiol. 2019 Jan-Mar;37(1):127-131. doi: 10.4103/ijmm.IJMM_19_94. Indian J Med Microbiol. 2019. PMID: 31424025 Free article. Review.
Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial.
Goodall RL, Nunn AJ, Meredith SK, Bayissa A, Bhatnagar AK, Chiang CY, Conradie F, Gopalan N, Gurumurthy M, Kirenga B, Kiria N, Meressa D, Moodliar R, Ngubane N, Rassool M, Sanders K, Solanki R, Squire SB, Teferi M, Torrea G, Tsogt B, Tudor E, Van Deun A, Rusen ID; STREAM study collaborators. Goodall RL, et al. Among authors: gopalan n. Lancet Respir Med. 2024 Dec;12(12):975-987. doi: 10.1016/S2213-2600(24)00186-3. Epub 2024 Oct 1. Lancet Respir Med. 2024. PMID: 39366400 Free article. Clinical Trial.
Correction: Attrition in serum anti-DENV antibodies correlates with high anti-SARS-CoV-2 IgG levels and low DENV positivity in mosquito vectors-Findings from a state-wide cluster-randomized community-based study in Tamil Nadu, India.
Selvavinayagam ST, Sankar S, Yong YK, Anshad AR, Chandramathi S, Somasundaram A, Palani S, Kumarasamy P, Azhaguvel R, Kumar AB, Subramaniam S, Malathi M, Vijayalakshmi V, Rajeshkumar M, Kumaresan A, Pandey RP, Muruganandam N, Gopalan N, Kannan M, Murugesan A, Balakrishnan P, Byrareddy SN, Dash AP, Velu V, Larsson M, Shankar EM, Raju S. Selvavinayagam ST, et al. Among authors: gopalan n. PLOS Glob Public Health. 2024 Dec 31;4(12):e0004157. doi: 10.1371/journal.pgph.0004157. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39739977 Free PMC article.
88 results